English Emily has filed 16 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 71000 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | A | Employee Stock Option (right to buy) | 71000 | $0.00 | 71,000.0000 | 26,003,606 | 9999.99% | 0.27% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | A | Common Stock | 24000 | $0.00 | 94,226.0000 | 26,003,606 | 34.18% | 0.09% |
| Dec. 30, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 19,369.0000 | 26,003,606 | 27.91% | 0.03% |
| Dec. 30, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 70,226.0000 | 26,003,606 | 11.96% | 0.03% |
| Nov. 28, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 26,869.0000 | 26,003,606 | 21.82% | 0.03% |
| Nov. 28, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 62,726.0000 | 26,003,606 | 13.58% | 0.03% |
| May 12, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 55,226.0000 | 25,936,101 | 15.71% | 0.03% |
| May 12, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 34,369.0000 | 25,936,101 | 17.91% | 0.03% |
| April 15, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Stock Option (Right to Buy) | 7500 | $0.00 | 41,869.0000 | 25,936,101 | 15.19% | 0.03% |
| April 15, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | M | Common Stock | 7500 | $3.30 | 47,726.0000 | 25,936,101 | 18.64% | 0.03% |
| Jan. 6, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | S | Common Stock | 906 | $16.83 | 40,226.0000 | 25,767,369 | 2.20% | 0.00% |
| Jan. 3, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | S | Common Stock | 891 | $16.72 | 41,132.0000 | 25,767,369 | 2.12% | 0.00% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | A | Employee Stock Option (right to buy) | 47400 | $0.00 | 47,400.0000 | 25,767,369 | 9999.99% | 0.18% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | Chief Operations Officer | A | Common Stock | 16100 | $0.00 | 42,023.0000 | 25,767,369 | 62.11% | 0.06% |
| Dec. 26, 2024 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | SVP, Head of Manufacturing | M | Common Stock | 7650 | $3.30 | 25,923.0000 | 23,896,525 | 41.87% | 0.03% |
| Dec. 26, 2024 | Cartesian Therapeutics, Inc. | $RNAC | English Emily | SVP, Head of Manufacturing | M | Stock Option (Right to Buy) | 7650 | $0.00 | 49,369.0000 | 23,896,525 | 13.42% | 0.03% |